Evidence first
Every claim is grounded in data. We design for clinical outcomes, not engagement vanity metrics, and we report the limits honestly.
An Aalto University spin-out from Espoo, Finland, building precision digital therapeutics for depression — starting with Meliora.
Our mission
Depression affects roughly 280 million people worldwide, and around 30% don't respond adequately to existing treatments. Antidepressants and psychotherapy help many — but they rarely address the cognitive deficits and fronto-parietal hypoactivity that keep people stuck.
Soihtu DTx exists to change that. We're building Meliora, the first personalized, precision digital therapeutic delivered as a video game for major depressive disorder. By pairing adaptive cognitive training with an immersive narrative, Meliora reaches the cognitive roots of depression through something people actually want to play.
We're a cross-disciplinary team that combines neuroscience, clinical psychology and game development — grounded in roughly a decade of research and committed to reporting our evidence as plainly as our ambition. Meliora is investigational and not yet cleared by regulators.
How we got here
2013
Our work begins as neuroscience research at Aalto University, studying cognition, engagement and the circuits disrupted in depression.
2023
Spun out of Aalto in Espoo, Finland, the company forms around a single idea: deliver a real depression treatment as a video game.
2023
Soihtu DTx joins the 2023 Techstars Accelerator, a global program supporting promising early-stage health and technology companies.
2024
Backing from Techstars, Innovestor, Newfund and the Aalto Start-Up Center funds clinical work and grows the team.
2025–2026
Large-scale trials of Meliora show significant symptom reduction — early results comparable to psychotherapy, reached faster.
What we stand for
Every claim is grounded in data. We design for clinical outcomes, not engagement vanity metrics, and we report the limits honestly.
Treatment only works if people return to it. We craft experiences patients genuinely want to play, day after day.
Neuroscience, psychology and game design in the same room — because precision mental health lives at the intersection.
Delivered as software, Meliora can reach people anywhere — without waitlists, clinic hours or geography getting in the way.
By the numbers
Years of neuroscience research behind Meliora
Euros raised to date (€)
Techstars Accelerator cohort
People affected by depression globally
Backed by Techstars · 2023
Soihtu DTx was selected into the 2023 Techstars Accelerator, joining a global program supporting the most promising early-stage health and technology companies — alongside investors Innovestor, Newfund and the Aalto Start-Up Center.
We're hiring across neuroscience, engineering and game design — and always glad to hear from clinicians, researchers and partners.